Patents by Inventor Anna Dixon

Anna Dixon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220205031
    Abstract: A method of nucleic acid amplification involving using a first modified primer which provides protection to the amplification product from exonuclease degradation and a second primer. The method provides a double stranded nucleic acid, one strand of which is degraded by a double strand nucleic acid specific exonuclease to form a single stranded nucleic acid, which is protected from exonuclease degradation.
    Type: Application
    Filed: November 9, 2021
    Publication date: June 30, 2022
    Inventors: Daniel Adlerstein, David Pearce, Anna Dixon, Wellington Fakanya
  • Patent number: 11180798
    Abstract: A method of nucleic acid amplification involving using a first modified primer which provides protection to the amplification product from exonuclease degradation and a second primer. The method provides a double stranded nucleic acid, one strand of which is degraded by a double strand nucleic acid specific exonuclease to form a single stranded nucleic acid, which is protected from exonuclease degradation.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: November 23, 2021
    Assignee: Binx Health Limited
    Inventors: Daniel Adlerstein, David M. Pearce, Anna Dixon, Wellington Fakanya